Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
502
502 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TTP399CadisegliatinPhase 32 trials
vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1
- YJ001Phase 32 trials
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)
- ZimislecelFormerly known as STx-02, VX-880Phase 32 trials
Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1
- AD-218Phase 31 trial
Addpharma Inc. · Mixed Dyslipidemia
- AD-218APhase 31 trial
Addpharma Inc. · Mixed Dyslipidemia
- AD-223APhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-223BPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-223CPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224APhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224BPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224CPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-227APhase 31 trial
Addpharma Inc. · Essential Hypertension
- AD-227BPhase 31 trial
Addpharma Inc. · Essential Hypertension
- AD-227CPhase 31 trial
Addpharma Inc. · Essential Hypertension
- AD-2281Phase 31 trial
Addpharma Inc. · Primary Hypercholesterolemia
- AD-2282Phase 31 trial
Addpharma Inc. · Primary Hypercholesterolemia
- AD-233APhase 31 trial
Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)
- AD-233BPhase 31 trial
Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)
- AD-233CPhase 31 trial
Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)
- AD-233DPhase 31 trial
Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)
- AG2304RPhase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia
- AG2304TPhase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia
- ATB-1011Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1012Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1013Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- AVT29proposed aflibercept HD biosimilarPhase 31 trial
Alvotech Swiss AG · Diabetic Macular Edema
- BE11164F-PCCPhase 31 trial
CSL Behring · Complex Cardiovascular Surgery With Cardiopulmonary Bypass
- BERLIM 2520 ASSOCIATIONPhase 31 trial
EMS · Dyslipidemia Associated With Type II Diabetes Mellitus
- BR1018APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1019APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- C2402Not ApplicablePhase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C2403Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C2407Phase 31 trial
JW Pharmaceutical · Dyslipidemia
- C52R1LPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- C52R1MPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- DA5221-B1Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-B2Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-T1Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-T2Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DLBS3233InlacinPhase 31 trial
Dexa Medica Group · Prediabetes
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.